Posted on March 17, 20213/17/21
Change Is Happening in the EU: What Pharma Companies Need to Know About the European Union’s New Pharmaceutical Strategy
Posted on December 9, 202012/9/20
COVID-19 Vaccine Safety Briefing Report
Posted on December 3, 202012/3/20
What Happens After a COVID-19 Vaccine Trial Succeeds? 4 Pharmacovigilance Challenges to Address During Commercialization
Posted on October 13, 202010/13/20
eBook – 2020 Stories That Shaped Commercialization
Posted on July 16, 20207/16/20
CMS Proposed Medicaid Rule: Best Price Impacts of Value-Based Purchasing, Co-Pay Assistance Programs, and More
Posted on July 2, 20207/2/20
ICER’s Alternative Pricing Models: New Threats to Biopharmaceutical’s Profitability and Innovation
Posted on June 28, 20206/28/20
COVID-19’s Impact on Brand Access
Posted on June 24, 20206/24/20
Brand Access Marketplace Dynamics: Respiratory
Posted on June 24, 20206/24/20
Brand Access Marketplace Dynamics: Multiple Sclerosis
Posted on June 24, 20206/24/20